About the Prohost Portfolio Tables

Today’s Highlights December 5, 2019

Firstly, Forty-Seven and IVERIC bio
We remind that the two condemned stocks Forty-Seven (FTSV) and IVERIC bio (This content is for paid subscribers.

Please click here to subscribe or here to log in.

Today’s Highlights
Amgen (AMGN), AstraZeneca Plc (AZN), Bristol-Myers Squibb (BMY), Forty Seven Inc (FTSV), Galapagos NV (GLPG), Gilead Sciences (GILD), Illumina (ILMN), IVERIC bio (ISEE), Merck (MRK), Novartis (NVS), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX)
December 5, 2019

Tweet Pin It

Other Articles

Why IVERIC bio Rallied Today

November 18, 2022 0

Gilead and MacroGenics Announce Oncology Collaboration to Develop Promising Bispecific Antibodies

October 17, 2022 0

Reata Pharmaceuticals: Good News for the Prohost Pick

October 14, 2022 0

From Biogen and Eisai: Lecanemab Confirmatory Phase 3 Clarity Met Primary Endpoint for Early Alzheimer’s Disease

September 28, 2022 0

Search ProhostBiotech

Popular Links
Aerie Pharmaceuticals (AERI) Agenus (AGEN) Alnylam Pharmaceuticals (ALNY) Amgen (AMGN) Array BioPharma (ARRY) AstraZeneca Plc (AZN) Bellicum Pharmaceuticals Inc (BLCM) Bristol-Myers Squibb (BMY) Celgene (CELG) Celldex Therapeutics (CLDX) Cellectis (CLLS) Celyad (CYAD) Compugen (CGEN) CRISPR Therapeutics (CRSP) Editas Medicine Inc (EDIT) Enanta Pharmaceuticals (ENTA) Exelixis (EXEL) Gilead Sciences (GILD) Halozyme Therapeutics (HALO) Illumina (ILMN) ImmunoGen (IMGN) Incyte (INCY) Innoviva (INVA) Intellia Therapeutics (NTLA) Ionis Pharmaceuticals Inc (IONS) Karyopharm Therapeutics Inc (KPTI) Merck (MRK) Moderna Inc (MRNA) Nektar Therapeutics (NKTR) Novartis (NVS) Portola Pharmaceuticals Inc (PTLA) PTC Therapeutics (PTCT) Regeneron Pharmaceuticals (REGN) Regenxbio (RGNX) Rhythm Pharmaceuticals Inc (RYTM) Sangamo Therapeutics Inc (SGMO) Sarepta Therapeutics (SRPT) Seagen Inc (SGEN) Spark Therapeutics Theravance Biopharma (TBPH) Vertex Pharmaceuticals (VRTX) Xoma (XOMA)

Recent

ProhostBiotech Archive
ProhostBiotech Archive
Sign Up for Weekly Emails
First Name

Last Name

Email address:

Exclusive Market Insight

& Scientific analysis

About the Prohost Portfolio Tables